BRIEF-FDA Approves Belzutifan-Lenvatinib Combination for Advanced Renal Cell Carcinoma With A Clear Cell Component
Reuters2026/09/24 19:21Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Sept 24 (Reuters) - FDA:
FDA APPROVES BELZUTIFAN IN COMBINATION WITH LENVATINIB FOR ADVANCED RENAL CELL CARCINOMA WITH A CLEAR CELL COMPONENT
FDA: RECOMMENDED DOSAGE IS 20 MG OF LENVATINIB IN COMBINATION WITH 120 MG OF BELZUTIFAN ONCE DAILY UNTIL DISEASE PROGRESSION OR UNACCEPTABLE TOXICITY
Further company coverage: MRK.N
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Walsh: Commercial investment may grow at a double-digit rate
Chaincatcher•2026/10/28 18:37
Dollar Index dips and recovers as the Fed holds with two hike votes
FXStreet•2026/10/28 18:33
Crypto prices
More
Bitcoin
BTC
$81,070.42
+0.67%
Ethereum
ETH
$2,355.66
+0.70%
Tether USDt
USDT
$0.9991
+0.05%
BNB
BNB
$750.84
+0.33%
XRP
XRP
$1.33
+0.37%
USDC
USDC
$0.9998
+0.01%
Solana
SOL
$102.09
+1.11%
TRON
TRX
$0.3297
+0.06%
Zcash
ZEC
$1,289.9
-0.44%
Hyperliquid
HYPE
$80.91
-0.53%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now